Frontiers in pharmacology · 2025
Identification, biotransformation, and neuroprotective potential of the ethanol extract of Alpiniae oxyphyllae fructus in neuroinflammation-related cognitive impairment.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yi Zirong, Wang Xinyu, Wang Lin, Yin Renfang, Qi Dongying, Liu Huan, Chen Yuxin, Xie Yamei, Ma Yuming, Hu Mengqi, Zhang Nan, Pan Yanli, Liu Yang, Wang Guopeng
Аннотация
BACKGROUND: Neuroinflammation is a key pathological mechanism underlying various central nervous system (CNS) disorders. Alpiniae Oxyphyllae Fructus (AOF), the dried fruit of Alpinia oxyphylla, has shown therapeutic potential for these disorders. This study aimed to characterize the chemical constituents, biotransformation profiles, and neuroprotective potential of the ethanol extract of AOF in neuroinflammation-related cognitive impairment.
METHODS: The ethanol extract of AOF was analyzed using ultra-performance liquid chromatography coupled with high-resolution mass spectrometry (UPLC-HRMS) and Global Natural Products Social Molecular Networking (GNPS). Sequential metabolism experiments were performed to investigate its dynamic biotransformation and blood-brain barrier (BBB) permeability. Neuroprotective effects of sesquiterpenoid-enriched fractions from AOF (SE-AOF) were evaluated in a lipopolysaccharide (LPS)-induced mouse model of neuroinflammation-associated cognitive impairment.
RESULTS: A total of 108 bioactive compounds were identified from the ethanol extract of AOF. Among them, 34 compounds, mainly sesquiterpenoids, were also detected in the cerebrospinal fluid and brain tissue, indicating BBB penetration. SE-AOF significantly improved cognitive function, reduced inflammatory cytokine levels, and alleviated oxidative stress in plasma and brain tissues of LPS-treated mice.
CONCLUSION: These findings demonstrate that the ethanol extract of AOF exerted neuroprotective effects via its bioactive sesquiterpenoids, providing insights into the therapeutic potential of natural products (NPs) against neuroinflammation-related CNS disorders.
METHODS: The ethanol extract of AOF was analyzed using ultra-performance liquid chromatography coupled with high-resolution mass spectrometry (UPLC-HRMS) and Global Natural Products Social Molecular Networking (GNPS). Sequential metabolism experiments were performed to investigate its dynamic biotransformation and blood-brain barrier (BBB) permeability. Neuroprotective effects of sesquiterpenoid-enriched fractions from AOF (SE-AOF) were evaluated in a lipopolysaccharide (LPS)-induced mouse model of neuroinflammation-associated cognitive impairment.
RESULTS: A total of 108 bioactive compounds were identified from the ethanol extract of AOF. Among them, 34 compounds, mainly sesquiterpenoids, were also detected in the cerebrospinal fluid and brain tissue, indicating BBB penetration. SE-AOF significantly improved cognitive function, reduced inflammatory cytokine levels, and alleviated oxidative stress in plasma and brain tissues of LPS-treated mice.
CONCLUSION: These findings demonstrate that the ethanol extract of AOF exerted neuroprotective effects via its bioactive sesquiterpenoids, providing insights into the therapeutic potential of natural products (NPs) against neuroinflammation-related CNS disorders.